Physician profile
Gregory Drake
NPI 1871507889
$4,355.34
in general payments reported to CMS, 2019-2025
23 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $2,689 · 2021: $334 · 2022: $56.43 · 2024: $76.67 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,613.88 | 2020 | |
| Medwest Associates | $827.00 | 2019-2020 | |
| Stryker Corporation | $720.23 | 2019-2025 | Blueprint Patient Specific Instrumentation, Alphavent, Aequalis Perform |
| Nuvasive, INC. | $281.10 | 2019-2021 | |
| Horizon Therapeutics Plc | $202.24 | 2019-2021 | |
| Orthofix Medical, INC. | $147.96 | 2019-2025 | Physio-Stim, Accelstim |
| Zimmer Biomet Holdings, INC. | $85.25 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $57.85 | 2025 | |
| Medtronic USA, INC. | $56.46 | 2019 | |
| Hydrocision, INC. | $52.45 | 2020 | |
| Ethicon US, LLC | $37.95 | 2022 | |
| Zyla Life Sciences, INC. | $34.22 | 2019 | |
| Kci USA, INC. | $31.21 | 2019 | |
| Medtronic, INC. | $29.03 | 2025 | Medtronic Reusable Instruments |
| Depuy Synthes Sales INC. | $26.25 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $24.11 | 2019 | |
| Surgalign Spine Technologies, INC. | $23.24 | 2020 | |
| Pacira Therapeutics, INC. | $20.97 | 2019 | |
| Assertio Therapeutics, INC. | $19.99 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.90 | 2019 | |
| Ibsa Pharma INC. | $18.48 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.21 | 2019 | |
| Fidia Pharma USA INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.